Fertility Treatment Success Found in IBD Patients
New research shows women with inflammatory bowel disease can achieve high pregnancy rates despite prior surgery or active disease.
Updated on Oct. 12, 2026 in Pregnancy
Live Poll
Do you feel fertility treatment options are becoming more accessible for women with chronic health conditions?
A study presented at the ACG Annual Scientific Meeting found that 85% of women with inflammatory bowel disease achieved pregnancy after embryo transfer. Researchers reported these positive outcomes remained consistent regardless of whether patients had active disease or previous pelvic surgeries.
Why it matters
This research provides critical evidence that women with inflammatory bowel disease have viable pathways to pregnancy using assisted reproductive technologies. It suggests that underlying disease severity or surgical history may not be the primary barriers to successful fertility treatment as previously hypothesized.
The study analyzed 67 women with inflammatory bowel disease who underwent fertility treatments out of a total cohort of 421 participants. Researchers observed that 42% of those treated required multiple attempts to achieve pregnancy.
The players
University of Minnesota
This public research university conducted the study analyzing pregnancy outcomes for women with inflammatory bowel disease.
ACG Annual Scientific Meeting
This major medical conference serves as a venue for gastroenterologists to review new clinical research and findings.
The details
Investigators from the University of Minnesota compared outcomes between women using intrauterine insemination and those using embryo transfer to determine predictors of success. The findings demonstrated a significantly higher efficacy rate for embryo transfer compared to intrauterine insemination in this patient population.
Timeline
October 12, 2026: Findings were presented at the ACG Annual Scientific Meeting in Nashville, Tennessee.
Culture Shift
The Women with Inflammatory Bowel Disease & Motherhood study challenges long-standing assumptions about reproductive health barriers for chronic patients. This shift reflects a growing medical focus on providing inclusive, effective family-planning support for women with complex autoimmune conditions.
Patients may find these results helpful when discussing treatment plans and success expectations with their reproductive endocrinologists. The findings offer a data-backed starting point for individuals weighing the comparative success rates of intrauterine insemination versus embryo transfer.
The takeaway
Patients with inflammatory bowel disease should consult their specialists to determine which fertility intervention is most appropriate for their specific medical history. These results emphasize that prior pelvic surgeries or active disease symptoms may not preclude a successful pregnancy journey.
Further reading
For more information on family planning and reproductive health, visit our Pregnancy section.
Source note: This article includes information reported by Healio.
Live Poll
Do you feel fertility treatment options are becoming more accessible for women with chronic health conditions?
